Active antiangiogenic therapy

Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiog...

Full description

Saved in:
Bibliographic Details
Main Authors Romero, Mónica Bequet, Acevedo Castro, Boris Ernesto, Gavilondo Cowley, Jorge Victor, Fernández Molina, Luis Enrique, Ocejo, Omar Lopez, Silva Rodriguez, Ricardo de la Caridad, Lasa, Alexis Musachio, Rodriguez, Ernesto Galban, Vázquez Blomquist, Dania Marcia
Format Patent
LanguageEnglish
Published 07.07.2009
Online AccessGet full text

Cover

Loading…
Abstract Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis.These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others.
AbstractList Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis.These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others.
Author Vázquez Blomquist, Dania Marcia
Lasa, Alexis Musachio
Ocejo, Omar Lopez
Romero, Mónica Bequet
Gavilondo Cowley, Jorge Victor
Silva Rodriguez, Ricardo de la Caridad
Acevedo Castro, Boris Ernesto
Fernández Molina, Luis Enrique
Rodriguez, Ernesto Galban
Author_xml – sequence: 1
  givenname: Mónica Bequet
  surname: Romero
  fullname: Romero, Mónica Bequet
– sequence: 2
  givenname: Boris Ernesto
  surname: Acevedo Castro
  fullname: Acevedo Castro, Boris Ernesto
– sequence: 3
  givenname: Jorge Victor
  surname: Gavilondo Cowley
  fullname: Gavilondo Cowley, Jorge Victor
– sequence: 4
  givenname: Luis Enrique
  surname: Fernández Molina
  fullname: Fernández Molina, Luis Enrique
– sequence: 5
  givenname: Omar Lopez
  surname: Ocejo
  fullname: Ocejo, Omar Lopez
– sequence: 6
  givenname: Ricardo de la Caridad
  surname: Silva Rodriguez
  fullname: Silva Rodriguez, Ricardo de la Caridad
– sequence: 7
  givenname: Alexis Musachio
  surname: Lasa
  fullname: Lasa, Alexis Musachio
– sequence: 8
  givenname: Ernesto Galban
  surname: Rodriguez
  fullname: Rodriguez, Ernesto Galban
– sequence: 9
  givenname: Dania Marcia
  surname: Vázquez Blomquist
  fullname: Vázquez Blomquist, Dania Marcia
BookMark eNrjYmDJy89L5WSQdUwuySxLVUjMK8lMzEvPzE9PzctMVijJSC1KLKjkYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDc1NTMwsDSmAglAJxFJxk
ContentType Patent
CorporateAuthor Centro De Ingenieria Genetica Y Biotechnologia
CorporateAuthor_xml – name: Centro De Ingenieria Genetica Y Biotechnologia
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 07556809
GroupedDBID EFH
ID FETCH-uspatents_grants_075568093
IEDL.DBID EFH
IngestDate Sun Mar 05 22:31:21 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_075568093
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556809
ParticipantIDs uspatents_grants_07556809
PatentNumber 7556809
PublicationCentury 2000
PublicationDate 20090707
PublicationDateYYYYMMDD 2009-07-07
PublicationDate_xml – month: 07
  year: 2009
  text: 20090707
  day: 07
PublicationDecade 2000
PublicationYear 2009
References Prewett, Marie, et al., "Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors", Cancer Research 1999, 59:5209-5218.
Rodriguez et al. (6149921) 20001100
Leggatt et al, J Immunology 161: 4728-4735, 1998.
Kobrin et al, J Immunology 146: 2017-2020, 1991.
Lu et al, J Biol Chemistry 275(19): 14321-14330, May 2000.
Stacker et al, J Biol Chemistry 274(49): 34884-92, Dec. 1999.
Siemeister et al, J Biol Chemistry 273(18): 11115-11120, 1998.
Kendall et al. (5712380) 19980100
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Davidoff, Andrew M., et al., "Bone Marrow-derived Cells Contribute to Tumor Neovasculature and, When Modified to Express an Angiogenesis Inhibitor, Can Restrict Tumor Growth in Mice", Clinical Cancer Research 2001, 7:2870-2879.
(WO 99/45018) 19990900
Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.
Wei, Yu-quan, et al., "Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen", PNAS 2001, 98(20):11545-11550.
(WO 00/53219) 20000900
References_xml – year: 20001100
  ident: 6149921
  contributor:
    fullname: Rodriguez et al.
– year: 19990900
  ident: WO 99/45018
– year: 19980100
  ident: 5712380
  contributor:
    fullname: Kendall et al.
– year: 20000900
  ident: WO 00/53219
Score 2.739972
Snippet Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and...
SourceID uspatents
SourceType Open Access Repository
Title Active antiangiogenic therapy
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7556809
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlLSQRWREm6KeZGprqgM6R0k0yMU3VTjBJNjJKSky0TwUMXvn5mHqEmXhGmEUwMHvC9MLnAbKRbAHRLsV5pcUFJPnhxJbB4h0S8LuTwZ9AZgXmg0wfK83LyE1MCUtL0zUFHaYF28jFbGICW9rm6eXAzcAKNADbZ8kqKkSoNN0EGtgCwqBADU2qeCIOsI7hoUQB6BRgl6Zn5wKjLTFaAbICqFGVQcHMNcfbQhZsVn14EWqMSbwC101iMgQXYV0-VYFCwNE0yTLW0TDJPTjMxMUi0BLolxTARCAyTTVMMUo0kGSRxGiOFR06agQsyjQEaV5RhYCkpKk2VBdaGJUlyYK8CABgsavw
link.rule.ids 230,309,783,805,888,64367
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUlLSQRWREm6KeZGprqgM6R0k0yMU3VTjBJNjJKSky0TwUMXvn5mHqEmXhGmEUwMHvC9MLnAbKRbAHRLsV5pcUFJPnhxJbB4h0S8LuTwZ9AZgXmg0wfK83LyE1MCUtL0zUFHaYF28rEC61gzcJfMzYObgRNoCLDRlldSjFRtuAkysAWARYUYmFLzRBhkHcGFiwLQM8BISc_MB0ZeZrICZAtUpSiDgptriLOHLtys-PQi0CqVeAOorcZiDCzA3nqqBIOCpWmSYaqlZZJ5cpqJiUGipYWBaYphIhAYJpumGKQaSTJI4jRGCo-cPANHgItbvI-nn7c0AxdkTgM0yCjDwFJSVJoqC6waS5LkwL4GAIedbfk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Active+antiangiogenic+therapy&rft.inventor=Romero%2C+M%C3%B3nica+Bequet&rft.inventor=Acevedo+Castro%2C+Boris+Ernesto&rft.inventor=Gavilondo+Cowley%2C+Jorge+Victor&rft.inventor=Fern%C3%A1ndez+Molina%2C+Luis+Enrique&rft.inventor=Ocejo%2C+Omar+Lopez&rft.inventor=Silva+Rodriguez%2C+Ricardo+de+la+Caridad&rft.inventor=Lasa%2C+Alexis+Musachio&rft.inventor=Rodriguez%2C+Ernesto+Galban&rft.inventor=V%C3%A1zquez+Blomquist%2C+Dania+Marcia&rft.number=7556809&rft.date=2009-07-07&rft.externalDBID=n%2Fa&rft.externalDocID=07556809